An established, vertically integrated company with innovative pipeline of antimicrobial products for the $25b wound care market as well as $6b ostomy market. 2015 projected revenue over $4m. FDA registered plant, 3rd party and branded B2B sales. Vendor relationships with 3 of the top 5 medical wholesalers. No competing antimicrobial/antifungal ostomy products where 1m end users spend $500 monthly for life. Experienced and successful team.